{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T21:14:39Z","timestamp":1762377279176,"version":"build-2065373602"},"reference-count":263,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.aprim.2022.102471","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T04:58:42Z","timestamp":1669179522000},"page":"102471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S1","title":["Actividades preventivas en la mujer. Actualizaci\u00f3n PAPPS 2022"],"prefix":"10.1016","volume":"54","author":[{"given":"Alberto","family":"L\u00f3pez Garc\u00eda-Franco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Baeyens Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Jos\u00e9","family":"Iglesias Pi\u00f1eiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Alonso Coello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Ruiz Cabello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Pereira Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacinta","family":"Landa Go\u00f1i","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2022.102471_bib1000","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(16)31470-2","article-title":"Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Kassebaum","year":"2016","journal-title":"Lancet."},{"year":"2017","series-title":"Indicadores de Salud 2017. Evoluci\u00f3n de los indicadores del estado de salud en Espa\u00f1a y su magnitud en el contexto de la Uni\u00f3n Europea","key":"10.1016\/j.aprim.2022.102471_bib1005"},{"key":"10.1016\/j.aprim.2022.102471_bib1010","first-page":"CD007950","article-title":"Effects and safety of periconceptional oral folate supplementation for preventing birth defects","author":"De-Regil","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1015","unstructured":"The Guide to clinical Preventive Service 2014. Recommendations of the U.S. Preventive Service Task Force. [consultado 1 Feb 2020]. Disponible en: https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/topic_search_results?topic_status=P&gender%5B%5D=14&searchterm="},{"key":"10.1016\/j.aprim.2022.102471_bib1020","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jama.2016.19193","article-title":"Folic Acid Supplementation for the Prevention of Neural Tube Defects","volume":"317","author":"Viswanathan","year":"2017","journal-title":"JAMA."},{"year":"2014","series-title":"Gu\u00eda de pr\u00e1ctica cl\u00ednica de atenci\u00f3n en el embarazo y puerperio","key":"10.1016\/j.aprim.2022.102471_bib1025"},{"year":"2020","series-title":"Management of epilepsy during preconception, pregnancy, and the postpartum period","author":"Pennell","key":"10.1016\/j.aprim.2022.102471_bib1030"},{"key":"10.1016\/j.aprim.2022.102471_bib1035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid."},{"key":"10.1016\/j.aprim.2022.102471_bib1040","unstructured":"National Institute for health and Clinical Excellence (NICE). Clinical guideline 2015. Diabetes in pregnancy: management from preconception to the postnatal period. [consultado 21 Mar 2020]. Disponible en: https:\/\/www.nice.org.uk\/guidance\/ng3\/chapter\/1-Recommendations#preconception-planning-and-care-2"},{"year":"2020","series-title":"Pregestational (preexisting) diabetes: Preconception counseling, evaluation, and management","author":"Morton-Egleston","key":"10.1016\/j.aprim.2022.102471_bib1045"},{"year":"2017","series-title":"Guidelines on hepatitis B and C testing","key":"10.1016\/j.aprim.2022.102471_bib1050"},{"key":"10.1016\/j.aprim.2022.102471_bib1055","first-page":"CD000934","article-title":"Alternative versus standard packages of antenatal care for low-risk pregnancy","author":"Dowswell","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib2295","article-title":"Protocolo de embarazo y puerperio","volume":"7","author":"Bail\u00f3n","year":"2000","journal-title":"FMC."},{"key":"10.1016\/j.aprim.2022.102471_bib1065","unstructured":"National Institute for health and Clinical Excellence (NICE). Antenatal care for uncomplicated pregnancies. Clinical guideline [CG62]. Published date: March 2008 Last updated: February 2019. [consultado 15 Feb 2020]. Disponible en: https:\/\/www.nice.org.uk\/guidance\/cg62"},{"journal-title":"Syphilis Infection in Pregnancy: Screening","year":"2018","key":"10.1016\/j.aprim.2022.102471_bib1070"},{"key":"10.1016\/j.aprim.2022.102471_bib1075","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/pd.4467","article-title":"Rubella and pregnancy: diagnosis, management and outcomes","volume":"34","author":"Bouthry","year":"2014","journal-title":"Prenat Diagn."},{"key":"10.1016\/j.aprim.2022.102471_bib1080","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1097\/01.AOG.0000466370.86393.d2","article-title":"Committee Opinion No: 635 Prenatal and Perinatal Human Immunodeficiency Virus Testing Expanded Recommendations","volume":"125","year":"2015","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.aprim.2022.102471_bib1085","doi-asserted-by":"crossref","first-page":"e687","DOI":"10.1016\/j.jogc.2018.05.036","article-title":"No. 285-Toxoplasmosis in Pregnancy: Prevention, Screening, and Treatment","volume":"40","author":"Paquet","year":"2018","journal-title":"J Obstet Gynaecol Can."},{"key":"10.1016\/j.aprim.2022.102471_bib1090","first-page":"CD006171","article-title":"Prenatal education for congenital toxoplasmosis","volume":"2015","author":"Di Mario","year":"2015","journal-title":"Cochrane database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1095","first-page":"68","article-title":"Enfermedad de Chagas abordaje de una afecci\u00f3n emergente en nuestro pais","volume":"16","author":"Salda\u00f1a","year":"2009","journal-title":"FMC."},{"key":"10.1016\/j.aprim.2022.102471_bib1100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.eimc.2008.04.006","article-title":"Cribado prenatal de la infecci\u00f3n por tripanosoma cruzi y virus linfotrofi cos humanos de celulas-T engestantes latinoamericanas","volume":"27","author":"Ramos","year":"2009","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.aprim.2022.102471_bib1105","unstructured":"U.S. Preventive Services Task Force. Reducing Risk for Mother-to-Infant Transmission of Hepatitis C Virus: A Systematic Review for the U.S. Preventive Services Task Force: Hepatitis C: Screening. Disponible en: https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/reducing-risk-for-mother-to-infant-transmission-of-hepatitis-c-virus-a-systematic-review-for-the-us-preventive-services-task-force\/hepatitis-c-screening#Pod3"},{"key":"10.1016\/j.aprim.2022.102471_bib1110","unstructured":"Agencia Espa\u00f1ola de Seguridad Alimentaria y Nutrici\u00f3n. Listeriosis. Actualizado a 18\/10\/2019. [consultado 30 Mar 2020]. Disponible en http:\/\/www.aecosan.msssi.gob.es\/AECOSAN\/web\/seguridad_alimentaria\/subdetalle\/listeria.htm"},{"key":"10.1016\/j.aprim.2022.102471_bib1115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.ede.0000152903.55579.15","article-title":"Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis","volume":"16","author":"Moretti","year":"2005","journal-title":"Epidemiology."},{"key":"10.1016\/j.aprim.2022.102471_bib1120","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijgo.2015.03.033","article-title":"A meta-analysis of risk of pregnancy loss and caffeine and coffee consumption during pregnancy","volume":"130","author":"Li","year":"2015","journal-title":"Int J Gynaecol Obstet."},{"key":"10.1016\/j.aprim.2022.102471_bib1125","unstructured":"Agencia de Evaluaci\u00f3n de Tecnolog\u00edas Valenciana y Vasca. Revisi\u00f3n espa\u00f1ola sobre los suplementos de Iodo y Ac. F\u00f3lico. Disponible en: http:\/\/www.osakidetza.euskadi.net\/contenidos\/informacion\/publicaciones_informes_estudio\/es_pub\/adjuntos\/Taller_yodo_embarazo_lactancia.pdf"},{"key":"10.1016\/j.aprim.2022.102471_bib1130","unstructured":"Pall\u00e1s Alonso C.R. Suplementos de yodo en la gestaci\u00f3n y la lactancia. Recomendaciones PrevInfad \/PAPPS [en l\u00ednea]. Actualizado mayo 2014. [consultado 25 Feb 2020]. Disponible en: http:\/\/previnfad.aepap.org\/monografia\/yodo"},{"key":"10.1016\/j.aprim.2022.102471_bib1135","first-page":"CD011761","article-title":"Iodine supplementation for women during the preconception, pregnancy and postpartum period","volume":"3","author":"Harding","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1140","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.endonu.2012.06.014","article-title":"Detecci\u00f3n de la disfunci\u00f3n tiroidea en la poblaci\u00f3n gestante: est\u00e1 justificado el cribado universal","volume":"59","author":"Vila","year":"2012","journal-title":"Endocrinol Nutr."},{"key":"10.1016\/j.aprim.2022.102471_bib1145","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.endonu.2015.03.007","article-title":"[Cost-effectiveness analysis of universal screening for thyroid disease in pregnant women in Spain]","volume":"62","author":"Donnay Candil","year":"2015","journal-title":"Endocrinol Nutr."},{"key":"10.1016\/j.aprim.2022.102471_bib1150","first-page":"CD011263","article-title":"Screening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health","volume":"2015","author":"Spencer","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1155","doi-asserted-by":"crossref","first-page":"e022837","DOI":"10.1136\/bmjopen-2018-022837","article-title":"Impact of levothyroxine therapy on obstetric, neonatal and childhood outcomes in women with subclinical hypothyroidism diagnosed in pregnancy: a systematic review and meta-analysis of randomised controlled trials","volume":"8","author":"Yamamoto","year":"2018","journal-title":"BMJ Open."},{"key":"10.1016\/j.aprim.2022.102471_bib1160","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/01.AOG.0000263932.05511.d4","article-title":"ACOG Committee Opinion No. 381: Subclinical hypothyroidism in pregnancy","volume":"110","year":"2007","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.aprim.2022.102471_bib1165","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the Treatment of Hypothyroidism","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid."},{"key":"10.1016\/j.aprim.2022.102471_bib1170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000362597","article-title":"European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children","volume":"3","author":"Lazarus","year":"2014","journal-title":"Eur Thyroid J."},{"key":"10.1016\/j.aprim.2022.102471_bib1175","first-page":"1315796","article-title":"Maternal Body Mass Index and Risk of Congenital Heart Defects in Infants: A Dose-Response Meta-Analysis","volume":"2019","author":"Liu","year":"2019","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.aprim.2022.102471_bib1180","first-page":"CD001231","article-title":"M\u00e9todos ambulatorios versus m\u00e9todos convencionales para el control de la presi\u00f3n arterial durante el embarazo","volume":"3","author":"Bergel","year":"2011","journal-title":"Cochrane Database of Systematic Reviews."},{"key":"10.1016\/j.aprim.2022.102471_bib2300","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.2016.18315","article-title":"Preeclampsia Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"317","author":"Henderson","year":"2017","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2022.102471_bib1190","first-page":"CD004659","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"2019","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.aprim.2022.102471_bib1200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16 weeks\u2019 gestation for preventing preeclampsia: an individual participant data meta-analysis","volume":"216","author":"Meher","year":"2017","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.aprim.2022.102471_bib1205","first-page":"CD000491","article-title":"Duration of Treatment for Asymptomatic bacteriuria during Pregnancy","volume":"2015","author":"Widmer","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.aprim.2022.102471_bib1210","doi-asserted-by":"crossref","first-page":"e1002391","DOI":"10.1371\/journal.pmed.1002391","article-title":"Preterm birth prevention\u2014Time to PROGRESS beyond progesterone","volume":"14","author":"Norman","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1215","first-page":"CD004947","article-title":"Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth","author":"Dodd","year":"2006","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1220","doi-asserted-by":"crossref","first-page":"414","DOI":"10.7326\/M13-2905","article-title":"Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1225","doi-asserted-by":"crossref","first-page":"e0175288","DOI":"10.1371\/journal.pone.0175288","article-title":"Risk factor screening to identify women requiring oral glucose tolerance testing to diagnose gestational diabetes: A systematic review and meta-analysis and analysis of two pregnancy cohorts","volume":"12","author":"Farrar","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.aprim.2022.102471_bib1230","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0304-5013(07)73182-5","article-title":"Gu\u00eda Asistencial 2006","volume":"50","year":"2007","journal-title":"Prog Obstet Ginecol."},{"key":"10.1016\/j.aprim.2022.102471_bib1235","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycaemia and adverse pregnancy outcomes. HAPO Study Cooperative Research Group","volume":"358","author":"Metzeger","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1240","first-page":"CD007122","article-title":"Different strategies for diagnosing gestational diabetes to improve maternal and infant health","volume":"1","author":"Farrar","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1245","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and Adverse Pregnancy Outcomes","volume":"358","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1250","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease \u2013revised guidelines from CDC, 2010","volume":"59","author":"Verani","year":"2010","journal-title":"MMWR Recomm Rep."},{"key":"10.1016\/j.aprim.2022.102471_bib1255","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cll.2010.04.004","article-title":"Additional first-trimester ultrasound markers","volume":"30","author":"Sonek","year":"2010","journal-title":"Clin Lab Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1260","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/uog.6412","article-title":"Prospective validation of first-trimester combined screening for trisomy 21","volume":"34","author":"Kagan","year":"2009","journal-title":"Ultrasound Obstet Gynecol."},{"key":"10.1016\/j.aprim.2022.102471_bib1265","first-page":"CD012600","article-title":"First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening","volume":"3","author":"Alldred","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1270","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/uog.14791","article-title":"Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis","volume":"45","author":"Gil","year":"2015","journal-title":"Ultrasound Obstet Gynecol."},{"key":"10.1016\/j.aprim.2022.102471_bib1275","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/aogs.13047","article-title":"Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis","volume":"96","author":"Iwarsson","year":"2017","journal-title":"Acta Obstet Gynecol Scand."},{"key":"10.1016\/j.aprim.2022.102471_bib1280","article-title":"Cribado prenatal para la detecci\u00f3n del s\u00edndrome de Down mediante el an\u00e1lisis de ADN fetal en sangre materna","author":"Bay\u00f3n","year":"2016","journal-title":"Ministerio de Sanidad, Servicios Sociales e Igualdad. Servicio de Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias del Pa\u00eds Vasco; Informes de Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias OSTEBA"},{"key":"10.1016\/j.aprim.2022.102471_bib1285","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.vaccine.2015.02.068","article-title":"Influenza vaccination during pregnancy: A systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes","volume":"33","author":"McMillan","year":"2015","journal-title":"Vaccine."},{"key":"10.1016\/j.aprim.2022.102471_bib1290","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/humrep\/det455","article-title":"Influenza and congenital anomalies: a systematic review and meta-analysis","volume":"29","author":"Luteijn","year":"2014","journal-title":"Hum Reprod."},{"key":"10.1016\/j.aprim.2022.102471_bib1295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6602a1","article-title":"Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season","volume":"66","author":"Grohskopf","year":"2017","journal-title":"MMWR Recomm Rep."},{"key":"10.1016\/j.aprim.2022.102471_bib1300","doi-asserted-by":"crossref","first-page":"e1475","DOI":"10.1542\/peds.2014-3925","article-title":"Strategies to Decrease Pertussis Transmission to Infants","volume":"135","author":"Forsyth","year":"2015","journal-title":"Pediatrics."},{"key":"10.1016\/j.aprim.2022.102471_bib1305","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12884-017-1559-2","article-title":"Efficacy and safety of pertussis vaccination for pregnant women \u2013 a systematic review of randomised controlled trials and observational studies","volume":"17","author":"Furuta","year":"2017","journal-title":"BMC Pregnancy Childbirth."},{"key":"10.1016\/j.aprim.2022.102471_bib1310","doi-asserted-by":"crossref","first-page":"g4219","DOI":"10.1136\/bmj.g4219","article-title":"Safety of pertussis vaccination in pregnant women in UK: observational study","volume":"349","author":"Donegan","year":"2014","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2022.102471_bib1315","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.vaccine.2014.12.062","article-title":"Combined tetanus-diphtheria and pertussis vaccine during pregnancy: transfer of maternal pertussis antibodies to the newborn","volume":"33","author":"Vilajeliu","year":"2015","journal-title":"Vaccine."},{"key":"10.1016\/j.aprim.2022.102471_bib1320","unstructured":"Grupo de Trabajo tosferina 2015 de la Ponencia de Programa y Registro de Vacunaciones. Adenda al programa de vacunaci\u00f3n frente a tos ferina en Espa\u00f1a: vacunaci\u00f3n en el embarazo. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad, 2015."},{"key":"10.1016\/j.aprim.2022.102471_bib1325","unstructured":"Asociaci\u00f3n Espa\u00f1ola de Vacunolog\u00eda. Vacunas y embarazo. [consultado 20 Feb 2020]. Disponible en: http:\/\/www.aev.es\/aev\/html\/necesita\/embVac.htm"},{"key":"10.1016\/j.aprim.2022.102471_bib1330","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest."},{"key":"10.1016\/j.aprim.2022.102471_bib1335","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/14767058.2014.913130","article-title":"Incidence of venous thromboembolism during pregnancy and the puerperium: a systematic review and meta-analysis","volume":"28","author":"Meng","year":"2015","journal-title":"J Matern Neonatal Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1340","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/jwh.2014.4872","article-title":"Intimate Partner Violence During Pregnancy: Maternal and Neonatal Outcomes","volume":"24","author":"Alhusen","year":"2015","journal-title":"J Womens Health (Larchmt)."},{"key":"10.1016\/j.aprim.2022.102471_bib1345","unstructured":"Manejo de la mujer embarazada y el reci\u00e9n nacido con COVID-19. Documento t\u00e9cnico versi\u00f3n de 17 de marzo de 2020. Centro de Coordinaci\u00f3n de Alertas y Emergencias Sanitarias. Direcci\u00f3n General de Salud P\u00fablica, Calidad e Innovaci\u00f3n. Ministerio de Sanidad. [consultado 02 Abril 2020]. Disponible en: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov-China\/documentos\/Documento_manejo_embarazo_recien_nacido.pdf"},{"key":"10.1016\/j.aprim.2022.102471_bib1350","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.15585\/mmwr.mm6650a4","article-title":"Update: Providing Quality Family Planning Services - Recommendations from CDC and the U.S Office of Population Affairs, 2017","volume":"66","author":"Gavin","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.aprim.2022.102471_bib1355","unstructured":"Observatorio de Salud Sexual y Reproductiva de la SEC. Encuesta de anticoncepci\u00f3n en Espa\u00f1a 2020. Disponible en: htpp:\/\/hosting.sec.es\/descargas\/Encuesta_%20anticoncepcion2020.pdf"},{"key":"10.1016\/j.aprim.2022.102471_bib1360","unstructured":"INE. Encuesta fecundiad 2018. Disponible en: http:\/\/ine.es"},{"key":"10.1016\/j.aprim.2022.102471_bib1365","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.amepre.2018.07.006","article-title":"Contraceptive Counseling in Clinical Settings: An Updated Systematic Review","volume":"55","author":"Zapata","year":"2018","journal-title":"Am J Prev Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1370","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.contraception.2012.07.015","article-title":"Structured contraceptive counseling provided by the Contraceptive CHOICE Project","volume":"88","author":"Madden","year":"2013","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2022.102471_bib1375","first-page":"2779","article-title":"Preventing unintended pregnancy: implications for physicians","volume":"69","author":"Lesnewski","year":"2004","journal-title":"Am Fam Physician."},{"key":"10.1016\/j.aprim.2022.102471_bib1380","doi-asserted-by":"crossref","unstructured":"ACOG Committee Opinion No 762. Prepregnancy Counseling. Obstet Gynecol 2019; 133(1):e78.","DOI":"10.1097\/AOG.0000000000003013"},{"key":"10.1016\/j.aprim.2022.102471_bib1385","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s11606-011-1647-3","article-title":"The Impact of Contraceptive Counseling in Primary Care on Contraceptive Use","volume":"26","author":"Lee","year":"2011","journal-title":"J Gen Intern Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1390","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.contraception.2021.12.005","article-title":"Increasing access to single \u2013visit contraception in urban health care settings: findings from a multi-site learning collaborative","volume":"108","author":"Jawatu","year":"2022","journal-title":"Contracepticon."},{"issue":"suppl 1","key":"10.1016\/j.aprim.2022.102471_bib1395","first-page":"39S","article-title":"Clinician\/patient interaction: communicating the benefits and risks of oral contraceptives","volume":"59","author":"Travis","year":"1999","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2022.102471_bib1400","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ypmed.2004.07.004","article-title":"Evaluation of a cognitive-behavioral, group, randomized controlled intervention trial to prevent sexually transmitted infections and unintended pregnancies in young women","volume":"40","author":"Boyer","year":"2005","journal-title":"Prev Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1405","first-page":"CD001863","article-title":"Education for contraceptive use by women after childbirth","volume":"2015","author":"Lopez","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1410","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1067\/mob.2003.308","article-title":"Patient satisfaction and the impact of written material about postpartum contraceptive decisions","volume":"188","author":"Johnson","year":"2003","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.aprim.2022.102471_bib1415","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(03)12770-5","article-title":"Postnatal home visits in teenage mothers: a randomised controlled trial","volume":"361","author":"Quinlivan","year":"2003","journal-title":"Lancet."},{"key":"10.1016\/j.aprim.2022.102471_bib1420","first-page":"CD011159","article-title":"Mobile phone-based interventions for improving contraception use","volume":"2015","author":"Smith","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1425","first-page":"195","article-title":"Sexuality and sex education at home and school","volume":"10","author":"Kirby","year":"1999","journal-title":"Adolesc Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1430","first-page":"CD012249","article-title":"School-based interventions for improving contraceptive use in adolescents","volume":"2016","author":"Lopez","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1435","unstructured":"World Health Organization Family planning: a global handbook ofr provider, evidence-based guidance developed through worlwide collatoration (internet). World Health Organization; 2018. Disponible en: htpp:\/\/apps.who.int\/iris\/handle\/10665\/260156"},{"key":"10.1016\/j.aprim.2022.102471_bib1440","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.amjmed.2005.02.029","article-title":"Prescription of teratogenic medications in United States ambulatory practices","volume":"118","author":"Schwarz","year":"2005","journal-title":"Am J Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1445","unstructured":"World Health Organization. Reproductive Health and research. Improving access to quality care in family planning. Medical eligibility criteria for contraceptive use. 5\u00aa edici\u00f3n. World Health Organization; 2015. Disponible en: http:\/\/apps.who.int\/iris\/bitstream\/10665\/181468\/1\/9789241549158_eng.pdf"},{"key":"10.1016\/j.aprim.2022.102471_bib1450","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/GRF.0000000000000337","article-title":"Patient-centered contraceptive counseling and prescribing","volume":"61","author":"Katherine","year":"2018","journal-title":"Clin Obstet and Gynecol."},{"key":"10.1016\/j.aprim.2022.102471_bib1455","unstructured":"Agencia de Calidad Sanitaria de Andaluc\u00eda, Consejer\u00eda de salud y familias. iContraception: Distintivo AppSaludable [Internet]. Disponible en: http:\/\/www.calidadappsalud.com\/distintivo\/info?app=iContraception"},{"key":"10.1016\/j.aprim.2022.102471_bib1460","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.contraception.2018.08.016","article-title":"Society of family planning clinical recommendations: contraception after surgical abortion","volume":"99","author":"Roe","year":"2019","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2022.102471_bib1465","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2022.102471_bib1470","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40834-017-0046-5","article-title":"Women's perceptions of contraceptive efficacy and safety","volume":"2","author":"Kakaiya","year":"2017","journal-title":"Contracept Reprod Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1475","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bpobgyn.2020.03.004","article-title":"Overview of modern contraception","volume":"66","author":"Festin","year":"2020","journal-title":"Best Pract Res Obstet Gynecol."},{"key":"10.1016\/j.aprim.2022.102471_bib1480","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.contraception.2013.10.003","article-title":"IUD use in France: women's and physician's perspectives","volume":"89","author":"Moreau","year":"2014","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2022.102471_bib1485","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.contraception.2007.05.085","article-title":"Attitudes towards long-acting reversible methods of contraception in general practice in the UK","volume":"76","author":"Wellings","year":"2007","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2022.102471_bib1490","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1783\/147118907781005100","article-title":"Training to fit intrauterine devices\/intrauterine systems for general practitioners: is there an alternative method of service delivery?","volume":"33","author":"Lee","year":"2007","journal-title":"J Fam Plann Reprod Health Care."},{"key":"10.1016\/j.aprim.2022.102471_bib1495","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.contraception.2009.04.003","article-title":"Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain","volume":"80","author":"Arribas-Mir","year":"2009","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2022.102471_bib1500","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.contraception.2011.03.001","article-title":"Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project","volume":"84","author":"Mestad","year":"2011","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2022.102471_bib1505","doi-asserted-by":"crossref","first-page":"115.e1","DOI":"10.1016\/j.ajog.2010.04.017","article-title":"The Contraceptive CHOICE Project: Reducing Barriers to Long-Acting Reversible Contraception","volume":"203","author":"Secura","year":"2010","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.aprim.2022.102471_bib1510","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.contraception.2015.10.003","article-title":"Projections and opinions from 100 experts in long-acting reversible contraception","volume":"92","author":"Foster","year":"2015","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2022.102471_bib1515","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ajog.2016.02.017","article-title":"Eliminating health disparities in unintenden pregnancy with long-acting reversible contraception (LARC)","volume":"214","author":"Parks","year":"2016","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.aprim.2022.102471_bib1520","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.contraception.2015.01.011","article-title":"Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices","volume":"91","author":"Heinemann","year":"2015","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2022.102471_bib1525","first-page":"567","article-title":"Preventing gaps when switching contraceptives","volume":"83","author":"Lesnewski","year":"2011","journal-title":"Am Fam Physician."},{"key":"10.1016\/j.aprim.2022.102471_bib1530","unstructured":"Faculty of Sexual & Reproductive Healthcare Clinical Guideline. Combined Hormonal contraception. January 2019 (Amended July 2019). Disponible en: http:\/\/www.fsrh.org\/pdfs\/CEUGuidanceCombinedHormonalContraception.pdf"},{"key":"10.1016\/j.aprim.2022.102471_bib1535","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention (CDC). MMWR U.S. Selected Practice Recommendations for Contraceptive Use [Internet]. 2016. Disponible en: https:\/\/www.cdc.gov\/mmwr\/volumes\/65\/rr\/pdfs\/rr6504.pdf","DOI":"10.15585\/mmwr.rr6504a1"},{"key":"10.1016\/j.aprim.2022.102471_bib1540","unstructured":"Sociedad Espa\u00f1ola de Contracepci\u00f3n. Conferencia de Consenso. Actualizaci\u00f3n de manejo cl\u00ednico de los anticonceptivos hormonales. [Internet]. 2005 [consultado 22 Mar 2020]. Disponible en: www.sec.es\/area_cientifica\/conferencias_ consenso\/index.php"},{"key":"10.1016\/j.aprim.2022.102471_bib1545","unstructured":"Sociedad Espa\u00f1ola de Contracepci\u00f3n. Conferencia de Consenso. Actualizaci\u00f3n en el manejo cl\u00ednico de la anticoncepci\u00f3n hormonal, intrauterina y de urgencia. [Internet]. 2011. Disponible en: www.sec.es\/area_cientifica\/conferencias_ consenso\/index.php"},{"key":"10.1016\/j.aprim.2022.102471_bib1550","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMcp030751","article-title":"Clinical practice, Combination estrogen-progestin oral contraceptives","volume":"349","author":"Petitti","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1555","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Anticonceptivos hormonales combinados: conclusiones de la revisi\u00f3n del riesgo de tromboembolismo venoso [Internet]. 2001. Disponible en: https:\/\/www.aemps.gob.es\/informa\/notasinformativas\/medicamentosusohumano-3\/seguridad-1\/2013\/ni-muh_fv_27-2013-anticonceptivos\/"},{"key":"10.1016\/j.aprim.2022.102471_bib1560","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.contraception.2018.09.001","article-title":"Pill, patch or ring? A mixed methods analysis of provider counseling about combined hormonal contraception","volume":"99","author":"Craig","year":"2019","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2022.102471_bib1565","doi-asserted-by":"crossref","first-page":"h6712","DOI":"10.1136\/bmj.h6712","article-title":"Maternal use of oral contraceptives and risk of birth defects in Denmark: prospective, nationwide cohort study","volume":"352","author":"Charlton","year":"2016","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2022.102471_bib1570","first-page":"CD010813","article-title":"Combined oral contraceptives: venous thrombosis","volume":"3","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1575","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.contraception.2016.10.005","article-title":"Nonoral combined hormonal contraceptives and thromboembolism: a systematic review","volume":"95","author":"Tepper","year":"2017","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2022.102471_bib1580","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int J Gynaecol Obstet."},{"key":"10.1016\/j.aprim.2022.102471_bib1585","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/13625187.2017.1372571","article-title":"Estradiol in hormonal contraception: real evolution or just same old wine in a new bottle?","volume":"22","author":"Grandi","year":"2017","journal-title":"Eur J Contracept Reprod Health Care."},{"key":"10.1016\/j.aprim.2022.102471_bib1590","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary Hormonal Contraception and the Risk of Breast Cancer","volume":"377","author":"M\u00f8rch","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1595","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1056\/NEJMe1709636","article-title":"Oral Contraceptives and the Small Increased Risk of Breast Cancer","volume":"377","author":"Hunter","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1600","doi-asserted-by":"crossref","unstructured":"Sociedad Espa\u00f1ola de Contracepci\u00f3n. Actualizaci\u00f3n del manejo cl\u00ednico de la anticoncepci\u00f3n intrauterina. Recomendaciones de la Conferencia de Consenso. Progresos de Obstetricia y Ginecolog\u00eda. 2002; 45(10):457.","DOI":"10.1016\/S0304-5013(02)75821-4"},{"key":"10.1016\/j.aprim.2022.102471_bib1605","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.contraception.2015.01.007","article-title":"Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices","volume":"91","author":"Heinemann","year":"2015","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2022.102471_bib1610","first-page":"CD001324","article-title":"Interventions for emergency contraception","volume":"1","author":"Shen","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1615","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1472-6874-14-54","article-title":"A systematic review of effectiveness and safety of different regimens of levonorgestrel oral tablets for emergency contraception","volume":"14","author":"Shohel","year":"2014","journal-title":"BMC Womens Health."},{"key":"10.1016\/j.aprim.2022.102471_bib1620","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJMcp1406328","article-title":"Clinical practice. Emergency contraception","volume":"372","author":"Raymond","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1625","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.aprim.2009.12.002","article-title":"Anticoncepci\u00f3n de urgencia 2010","volume":"42","author":"Arribas Mir","year":"2010","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2022.102471_bib1630","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clinthera.2011.11.012","article-title":"Ulipristal acetate: review of the efficacy and safety of a newly approved agent for emergency contraception","volume":"34","author":"Richardson","year":"2012","journal-title":"Clin Ther."},{"key":"10.1016\/j.aprim.2022.102471_bib1635","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.contraception.2011.02.009","article-title":"Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel","volume":"84","author":"Glasier","year":"2011","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2022.102471_bib1640","unstructured":"Trussell J, Raymond EG, Cleland K. Emergency Contraception:1; A Last Chance to Prevent Unintended Pregnancy. Pricenton University. 2017. Disponible en: http:\/\/ec.princeton.edu\/questions\/ec-review.pdf"},{"key":"10.1016\/j.aprim.2022.102471_bib1645","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/bmj.326.7393.775","article-title":"Emergency contraception","volume":"326","year":"2003","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2022.102471_bib1650","unstructured":"Agencia Espa\u00f1ola de medicamentos y productos sanitarios (AEMPS). Esmya (acetato de ulipristal 5 mg): levantamiento de la suspensi\u00f3n de comercializaci\u00f3n, con restricciones en sus indicaciones debido al riesgo de da\u00f1o hep\u00e1tico grave. MUH (FV) 05\/2021. htps:\/\/aemps.gob.es\/nforma\/notas informativas\/medicamentosusohumano-3\/seguridad-1\/2021-seguridad-1\/esmya-acetato-de-ulipristal-5-mg-levantamiento-de-la-suspension"},{"key":"10.1016\/j.aprim.2022.102471_bib1655","unstructured":"OMS. Anticoncepci\u00f3n de urgencia. [consultado 25 mayo 2022]. Disponible en htpp:\/who.int\/es\/news-room\/fact-sheet\/detail\/emergency-contraception"},{"key":"10.1016\/j.aprim.2022.102471_bib1660","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.contraception.2016.08.007","article-title":"Removing medical barriers to contraception \u2014 evidence-based recommendations from the Centers for Disease Control and Prevention, 2016","volume":"94","author":"Curtis","year":"2016","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2022.102471_bib1665","first-page":"CD001777","article-title":"Immediate postabortal insertion of intrauterine devices","volume":"2014","author":"Okusanya","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1670","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.2011.382","article-title":"Equine Estrogens Among Postmenopausal Women With Prior Hysterectomy A Randomized Controlled Trial","volume":"305","author":"La croix","year":"2011","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2022.102471_bib1675","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.contraception.2011.11.004","article-title":"Primary care physicians\u2019 perceptions of rates of unintended pregnancy","volume":"86","author":"Parisi","year":"2012","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2022.102471_bib1680","first-page":"CD008536","article-title":"Short-term and long-term effects of tibolone in postmenopausal women","volume":"10","author":"Formoso","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1685","first-page":"CD002978","article-title":"Oral oestrogen and combined oestrogen\/progestogen therapy versus placebo for hot flushes","volume":"2004","author":"MacLennan","year":"2004","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1690","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","author":"Suckling","year":"2006","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1695","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/13697130701611267","article-title":"Influence of menopause on mood: a systematic review of cohort studies","volume":"10","author":"Vesco","year":"2007","journal-title":"Climacteric."},{"key":"10.1016\/j.aprim.2022.102471_bib1700","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamainternmed.2014.8063","article-title":"Duration of menopausal vasomotor symptoms over the menopause transition","volume":"175","author":"Avis","year":"2015","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1705","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.maturitas.2009.10.016","article-title":"The impact of attitudes towards the menopause on women's symptom experience: a systematic review","volume":"65","author":"Ayers","year":"2010","journal-title":"Maturitas."},{"key":"10.1016\/j.aprim.2022.102471_bib1710","first-page":"e690693","article-title":"Normalising menopause","volume":"377","author":"Hickey","year":"2022","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2022.102471_bib1715","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jamapsychiatry.2017.3945","article-title":"Should Hormone Therapy Be Used to Prevent Depressive Symptoms During the Menopause Transition?","volume":"75","author":"Joffe","year":"2018","journal-title":"JAMA Psychiatry."},{"key":"10.1016\/j.aprim.2022.102471_bib1720","first-page":"CD005131","article-title":"Oestrogens for preventing recurrent urinary tract infection in postmenopausal women","author":"Perrotta","year":"2008","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1725","first-page":"CD001405","article-title":"Oestrogen therapy for urinary incontinence in post menopausal women","volume":"10","author":"Cody","year":"2012","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1730","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jama.293.8.935","article-title":"Effects of estrogen with an without progestin on urinary incontinence","volume":"293","author":"Hendrix","year":"2005","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2022.102471_bib1735","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/bmj.39188.594282.80","article-title":"Postmenopausal therapy, Sympton should be treatment with lowest effective dose of hormone therapy for the shortest time possible","volume":"334","author":"Grady","year":"2007","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2022.102471_bib1740","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.aprim.2009.03.007","article-title":"\u00bfDebemos cambiar de actitud sobre el tratamiento hormonal en la mujer posmenop\u00e1usica?","volume":"41","author":"L\u00f3pez Garc\u00eda-Franco","year":"2009","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2022.102471_bib1745","doi-asserted-by":"crossref","first-page":"20631","DOI":"10.1038\/s41598-020-77534-9","article-title":"A systematic review and meta-analysis of effects of menopausal hormone therapy on cardiovascular diseases","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep."},{"key":"10.1016\/j.aprim.2022.102471_bib1750","unstructured":"Sociedad Espa\u00f1ola de Ginecolog\u00eda y Obstetricia. Comunicado AEEM-SEGO sobre terapia hormonal. [consultado 19 Ene 2009]. Disponible en: http:\/\/www.acienginecologia.com\/site_media\/comunicado-sego-aeem-08.pdf"},{"key":"10.1016\/j.aprim.2022.102471_bib1755","article-title":"Long-term hormone therapy for perimenopausal and postmenopausal women","volume":"1","author":"Marjoribanks","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1760","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risk and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women. Principal Results from the women's Health Inititive Randomized Controlled Trial","volume":"288","year":"2002","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2022.102471_bib1765","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmj.39266.425069.AD","article-title":"Main morbidities recorded in teh women's international study of long duration oestrogen aftermenopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women","volume":"335","author":"Vickers","year":"2007","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2022.102471_bib1770","first-page":"CD002229","article-title":"Terapia hormonal para la prevenci\u00f3n de las enfermedades cardiovasculares en mujeres posmenop\u00e1usicas","author":"Boardman","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1775","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2022.102471_bib1780","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogens in postmenopausal women with hysterectomy","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA."},{"issue":"10204","key":"10.1016\/j.aprim.2022.102471_bib1785","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","year":"2019","journal-title":"Lancet."},{"key":"10.1016\/j.aprim.2022.102471_bib1790","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidenceof probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study","volume":"291","author":"Shumaker","year":"2004","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2022.102471_bib1795","unstructured":"Bitn. Servicio Navarro de Salud. Osasunbidea. Disponible en: http:\/\/www.navarra.es\/NR\/rdonlyres\/D411C051-42BE-4B05-B2B5-D7ECE9657B96\/402664\/FET_2017_6.pdf"},{"key":"10.1016\/j.aprim.2022.102471_bib1800","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/eurheartj\/ehn299","article-title":"Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis","volume":"29","author":"Sare","year":"2008","journal-title":"Eur Heart J."},{"key":"10.1016\/j.aprim.2022.102471_bib1805","unstructured":"Martin K.A. Barbieri R.L. Menopausal hormone therapy: Benefits and risks. Snyder P.J. Crowley W.F. Mulder J.E. UpToDate. [consultado 5-2022]. Disponible en: https:\/\/www.uptodate.com\/contents\/menopausal-hormone-therapy-benefits-and-risks"},{"key":"10.1016\/j.aprim.2022.102471_bib1810","first-page":"CD003799","article-title":"Hormone replacement therapy to maintain cognitive function in women with dementia","volume":"2009","author":"Hogervorst","year":"2009","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1815","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.2017.11217","article-title":"Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific MortalityThe Women's Health Initiative Randomized Trials","volume":"318","author":"Manson","year":"2017","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2022.102471_bib1820","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMcp1714787","article-title":"Hormone Therapy for postmenopausal women","volume":"382","author":"Pinkerton","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2022.102471_bib2305","first-page":"CD001405","article-title":"Oestrogen therapy for urinary incontinence in post-menopausal women","volume":"4","author":"Cody","year":"2009","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1830","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapyand risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis","volume":"336","author":"Canonico","year":"2008","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2022.102471_bib1835","doi-asserted-by":"crossref","first-page":"k4810","DOI":"10.1136\/bmj.k4810","article-title":"Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"364","author":"Vinogradova","year":"2019","journal-title":"BMJ."},{"issue":"Suppl 12B","key":"10.1016\/j.aprim.2022.102471_bib1840","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.amjmed.2005.09.049","article-title":"Lifestyle factors: are they related to vasomotor symptoms, and do they modify the effectiveness or side effects of hormone therapy?","volume":"118","author":"Greendale","year":"2005","journal-title":"Am J Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1845","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.maturitas.2011.07.010","article-title":"Methods used in cross-cultural comparisons of vasomotor symptoms and their determinants","volume":"70","author":"Melby","year":"2011","journal-title":"Maturitas."},{"key":"10.1016\/j.aprim.2022.102471_bib1850","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/aje\/kwp203","article-title":"Gains in body fat and vasomotor symptom reporting over the menopausal transition: the study of women's health across the nation","volume":"170","author":"Thurston","year":"2009","journal-title":"Am J Epidemiol."},{"key":"10.1016\/j.aprim.2022.102471_bib1855","doi-asserted-by":"crossref","first-page":"E1588","DOI":"10.1210\/jc.2011-1082","article-title":"Adiposity and hot flashes in midlife women: a modifying role of age","volume":"96","author":"Thurston","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.aprim.2022.102471_bib1860","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archinternmed.2010.162","article-title":"An Intensive Behavioral Weight Loss Intervention and Hot Flushes in Women","volume":"170","author":"Huang","year":"2010","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1865","first-page":"CD006108","article-title":"Exercise for vasomotor menopausal symptoms","author":"Daley","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1870","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3109\/07853890.2011.583674","article-title":"Effect of aerobic training on hot flushes and quality of life--a randomized controlled trial","volume":"44","author":"Luoto","year":"2012","journal-title":"Ann Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1875","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/jamainternmed.2018.5233","article-title":"Associations of intimate partner violence, sexual assault, and posttraumatic stress disorder with menopause symptoms amongmidlife and older women","volume":"179","author":"Gibson","year":"2019","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1880","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","article-title":"Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis","volume":"295","author":"Nelson","year":"2006","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2022.102471_bib1885","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1592\/phco.29.11.1357","article-title":"Use of Antidepressants for Management of Hot Flashes","volume":"29","author":"Carroll","year":"2009","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.aprim.2022.102471_bib1890","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2147\/IJWH.S50804","article-title":"Critical appraisal of paroxetine for the treatment of vasomotor symptoms","volume":"7","author":"Carrol","year":"2015","journal-title":"Int J Womens Health."},{"key":"10.1016\/j.aprim.2022.102471_bib1895","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/AOG.0000000000000927","article-title":"Pooled Analysis of six pharmacologic and non pharmacologic interventios for vasomotor symptoms","volume":"126","author":"Guthrie","year":"2015","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.aprim.2022.102471_bib1900","first-page":"272","article-title":"Do SSRIs and SNRIs reduce the frequency and\/or severity of hot flashes in menopausal women","volume":"110","author":"Stubbs","year":"2017","journal-title":"J Okla State Med Assoc."},{"key":"10.1016\/j.aprim.2022.102471_bib1905","first-page":"173","article-title":"The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials","volume":"47","author":"Azizi","year":"2022","journal-title":"Iran J Med Sci."},{"key":"10.1016\/j.aprim.2022.102471_bib1910","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11606-013-2535-9","article-title":"SSRIs for hot flashes: a systematic review and meta-analysis of randomized trials","volume":"29","author":"Shams","year":"2014","journal-title":"J Gen Intern Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1915","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10549-016-3765-4","article-title":"Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions","volume":"156","author":"Johns","year":"2016","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.aprim.2022.102471_bib1920","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ajog.2019.12.011","article-title":"Efficacy and safety of gabapentin and pregabalin in patients with vasomotor symptoms: a systematic review and meta-analysis","volume":"222","author":"Shan","year":"2020","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.aprim.2022.102471_bib1925","unstructured":"Menopause: diagnosis and management. NICE guideline [NG23] Published: 12 November 2015. Last updated: 05 December 2019 Overview | Menopause: diagnosis and management | Guidance | NICE."},{"key":"10.1016\/j.aprim.2022.102471_bib1930","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/archinte.166.14.1453","article-title":"Complementary and alternative therapies for the management of menopause related Sumptoms. A systematic Evidence Review","volume":"166","author":"Nedrow","year":"2006","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1935","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1001\/jama.2016.8012","article-title":"Use of plant-based therapies and menopausal symptoms: A systematic review and meta-analysis","volume":"315","author":"Franco","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.aprim.2022.102471_bib1940","first-page":"CD001395","article-title":"Phytoestrogens for menopausal vasomotor symtoms","volume":"12","author":"Lethabay","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib1945","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/gme.0b013e3181cb4fb5","article-title":"Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: Systematic review and meta-analysis","volume":"17","author":"Bola\u00f1os","year":"2010","journal-title":"Menopause."},{"key":"10.1016\/j.aprim.2022.102471_bib1950","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/gme.0b013e3182410159","article-title":"Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Taku","year":"2012","journal-title":"Menopause."},{"key":"10.1016\/j.aprim.2022.102471_bib1955","doi-asserted-by":"crossref","DOI":"10.1177\/2515690X19829380","article-title":"Complementary and alternative medicine for menopause","volume":"24","author":"Johnson","year":"2019","journal-title":"J Evid Based Integr Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1960","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejogrb.2021.03.039","article-title":"Impact of phytoestrogens on treatment of urogenital menopause symptoms: A systematic review of randomized clinical trials","volume":"261","author":"Abdi","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"10.1016\/j.aprim.2022.102471_bib1965","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.maturitas.2014.05.007","article-title":"Effects of isoflavones and amino acid therapies for hot flashes and co-ocurring symptoms during the menopausal transition and early postmenopause: a systematic review","volume":"78","author":"Thomas","year":"2014","journal-title":"Maturitas."},{"key":"10.1016\/j.aprim.2022.102471_bib1970","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clnu.2007.10.012","article-title":"Soy isoflavone intake increases bone mineral density in the spine of menopausal women. Meta-analysis of randomized controlled trials","volume":"27","author":"Ma","year":"2008","journal-title":"Clinical Nutrition."},{"key":"10.1016\/j.aprim.2022.102471_bib1975","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jocd.2013.08.011","article-title":"Phytoestrogens in the prevention of postmenopausal bone loss","volume":"16","author":"Lagari","year":"2013","journal-title":"J Clin Densitom."},{"key":"10.1016\/j.aprim.2022.102471_bib1980","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2009.04.018","article-title":"Side effects of phytoestrogens: a meta-analysis of randomized trials","volume":"122","author":"Tempfer","year":"2009","journal-title":"Am J Med."},{"key":"10.1016\/j.aprim.2022.102471_bib1985","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ajcn\/79.2.282","article-title":"Dietary phytoestrogens and breast cancer risk","volume":"79","author":"Keinan-Boker","year":"2004","journal-title":"Am J Clin Nutr."},{"key":"10.1016\/j.aprim.2022.102471_bib1990","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.bjc.6605003","article-title":"Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies","volume":"100","author":"Velentzis","year":"2009","journal-title":"Br J Cancer."},{"key":"10.1016\/j.aprim.2022.102471_bib1995","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3945\/an.114.008052","article-title":"Genistein and cancer: current status, challenges, and future directions","volume":"6","author":"Spaqnuolo","year":"2015","journal-title":"Adv Nutr."},{"key":"10.1016\/j.aprim.2022.102471_bib2000","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2796.2003.01232.x","article-title":"Fracture risk associated with smoking: a meta-analysis","volume":"254","author":"Vestergaard","year":"2003","journal-title":"J Intern Med."},{"key":"10.1016\/j.aprim.2022.102471_bib2005","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.315.7112.841","article-title":"A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect","volume":"315","author":"Law","year":"1997","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2022.102471_bib2010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00198-004-1780-5","article-title":"Assessment of fracture risk","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.aprim.2022.102471_bib2015","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000333.pub2","article-title":"Exercise for preventing and treating osteoporosis in postmenopausal women","author":"Howe","year":"2011","journal-title":"Cochrane Database of Systematic Reviews."},{"key":"10.1016\/j.aprim.2022.102471_bib2020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2519\/jospt.2017.6969","article-title":"The effectiveness of combined exercise intenventions for preventing postmenopausal bone loss: a systematic review and meta-analysis","volume":"47","author":"Zhao","year":"2017","journal-title":"J Orthop Sports Phys Ther."},{"key":"10.1016\/j.aprim.2022.102471_bib2025","doi-asserted-by":"crossref","first-page":"815","DOI":"10.7326\/0003-4819-153-12-201012210-00008","article-title":"Primary Care\u2013Relevant Interventions to Prevent Falling in Older Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force","volume":"153","author":"Michael","year":"2010","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.aprim.2022.102471_bib2030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/bmj.39412.525243.BE","article-title":"Multifactorial assessment and targeted intervention for preventing falls and injuries among older people in community and emergency care settings: systematic review and meta-analysis","volume":"336","author":"Gates","year":"2008","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2022.102471_bib2035","first-page":"f6234","article-title":"The effect of fall prevention exercise programmes on fall induced injuries in community dwelling older adults: systematic review and meta-analysis of randomised controlled trials","volume":"347","author":"El-Khoury","year":"2013","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2022.102471_bib2040","first-page":"CD007146","article-title":"Interventions for preventing falls in older people living in the community","volume":"2012","author":"Gillespie","year":"2012","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib2045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00198-005-1942-0","article-title":"Lifestyle interventions to prevent osteoporotic fractures: a systematic review","volume":"17","author":"Lock","year":"2006","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.aprim.2022.102471_bib2050","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1001\/jama.293.18.2257","article-title":"Fracture Prevention with Vitamin D supplementation. A meta-analysis of Randomized controlled trials","volume":"293","author":"Bischoff-Ferrari","year":"2005","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2022.102471_bib2055","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/archinternmed.2008.600","article-title":"Prevention of non vertebral fractures with oral vit D and dose dependency","volume":"169","author":"Bischoff-Ferrari","year":"2009","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.aprim.2022.102471_bib2060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa1109617","article-title":"A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention","volume":"367","author":"Bischorr-Ferrari","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2022.102471_bib2065","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)61342-7","article-title":"Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis","volume":"370","author":"Tang","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2022.102471_bib2070","doi-asserted-by":"crossref","first-page":"b5463","DOI":"10.1136\/bmj.b5463","article-title":"Patient level pooled analysis of 68.500 patients from seven major vitamin D fracture trials in US and Europe","volume":"340","year":"2010","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2022.102471_bib2075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00198-012-2224-2","article-title":"Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study","volume":"24","author":"Prentice","year":"2013","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.aprim.2022.102471_bib2080","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00198-015-3386-5","article-title":"Calcium plus Vitamin D supplementation and risk of fracture: an updated meta-analysys from the National Osteoporosis Foundation","volume":"27","author":"Weaver","year":"2016","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.aprim.2022.102471_bib2085","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/bmj.330.7498.1003","article-title":"Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamina D3) for prevention of fractures in primary care","volume":"330","author":"Porthouse","year":"2005","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2022.102471_bib2090","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(05)63013-9","article-title":"Oral vitamin D3 and calcium for secondary prevention of low trauma fractures in elderly people (Randomised evaluation of calcium or vitamin D, RECORD): a randomised placebo-controlled trial","volume":"365","author":"Grant A.","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.aprim.2022.102471_bib2095","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"Jackson","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2022.102471_bib2100","doi-asserted-by":"crossref","first-page":"h4580","DOI":"10.1136\/bmj.h4580","article-title":"Calcium intake and risk of fracture: systematic review","author":"Bolland","year":"2015","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2022.102471_bib2105","doi-asserted-by":"crossref","first-page":"g2035","DOI":"10.1136\/bmj.g2035","article-title":"Vitamin D and multiple health outcomes: umbrela review of systematic review and meta-analyses of observational studies and randomised trials","volume":"348","author":"Theodoratou","year":"2014","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2022.102471_bib2110","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1001\/jama.2018.3185","article-title":"Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: US Preventive Services Task Force Recommendation Statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2022.102471_bib2115","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1001\/jama.2017.19344","article-title":"Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis","volume":"318","author":"Jia-Guo Zhao","year":"2017","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2022.102471_bib2120","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(18)30265-1","article-title":"Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis","volume":"6","author":"Bolland","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.aprim.2022.102471_bib2125","doi-asserted-by":"crossref","first-page":"e1917789","DOI":"10.1001\/jamanetworkopen.2019.17789","article-title":"Vitamin D and Calcium for the Prevention of Fracture. A Systematic Review and Meta-analysis","volume":"2","author":"Yao","year":"2019","journal-title":"JAMA Network Open."},{"key":"10.1016\/j.aprim.2022.102471_bib2130","doi-asserted-by":"crossref","first-page":"n2364","DOI":"10.1136\/bmj.n2364","article-title":"Effect of dietary sources of calcium and protein on hip fractures and falls in older adults in residential care: cluster randomised controlled trial","volume":"375","author":"Iuliano","year":"2021","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2022.102471_bib2135","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/jama.2021.3069","article-title":"Screening for Vitamin D Deficiency in Adults: US Preventive Services Task Force Recommendation Statement","volume":"325","author":"Krist","year":"2021","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2022.102471_bib2140","first-page":"1","article-title":"Bone density measurement--a systematic review. A report from SBU, the Swedish Council on Technology Assessment in Health Care","volume":"739","year":"1997","journal-title":"J Intern Med."},{"key":"10.1016\/j.aprim.2022.102471_bib2145","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.berh.2005.06.001","article-title":"Assessment of fracture risk: who should be treated for osteoporosis?","volume":"19","author":"van der Klift","year":"2005","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"10.1016\/j.aprim.2022.102471_bib2150","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/er.2001-2002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analyses of alendronate for the treatment of postmenopausal women","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev."},{"key":"10.1016\/j.aprim.2022.102471_bib2155","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1471-2474-13-204","article-title":"FRAX\u00ae tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort","volume":"13","author":"Azagra","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.aprim.2022.102471_bib2160","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s001980070064","article-title":"Long-term risk of osteoporotic fracture in Malm\u00f6","volume":"11","author":"Kanis","year":"2000","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.aprim.2022.102471_bib2165","unstructured":"Agency for Healthcare Research and Quality. U.S. Department of Health and Human Services. www.ahrq.gov."},{"key":"10.1016\/j.aprim.2022.102471_bib2170","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/GME.0000000000001831","article-title":"Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society","volume":"28","year":"2021","journal-title":"Menopause"},{"key":"10.1016\/j.aprim.2022.102471_bib2175","unstructured":"National Osteoporosis Guideline Group. NOGG 2021: Clinical guideline for the prevention and treatment of osteoporosis. 2021. Disponible en: www.nogg.org.uk"},{"key":"10.1016\/j.aprim.2022.102471_bib2180","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). Management of osteoporosis and the prevention of fragility fractures. Edinburgh: SIGN; 2021 (SIGN publication no. 142). [January 2021]. Disponible en: URL: http:\/\/www.sign.ac.uk"},{"key":"10.1016\/j.aprim.2022.102471_bib2185","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1503\/cmaj.100771","article-title":"2010 Clinical Practice Guidelines for the diagnosis and management of osteoporosis in Canada: summary","volume":"182","author":"Papaioannou","year":"2010","journal-title":"CMAJ."},{"key":"10.1016\/j.aprim.2022.102471_bib2190","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11657-016-0278-z","volume":"11","author":"Kanis","year":"2016","journal-title":"Arch Osteoporos."},{"key":"10.1016\/j.aprim.2022.102471_bib2195","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jocd.2017.06.008","article-title":"Worlwide Fracture Prediction","volume":"20","author":"Fuleihan","year":"2017","journal-title":"J Clin Densitom."},{"key":"10.1016\/j.aprim.2022.102471_bib2200","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-018-4704-5","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.aprim.2022.102471_bib2205","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's Guide to Prevention and Treatment of Osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.aprim.2022.102471_bib2210","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1359\/jbmr.081203","article-title":"Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines","volume":"24","author":"Donaldson","year":"2009","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.aprim.2022.102471_bib2215","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00198-017-4326-3","article-title":"Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study","volume":"29","author":"Rubin","year":"2018","journal-title":"Osteoporos Int."},{"issue":"10122","key":"10.1016\/j.aprim.2022.102471_bib2220","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","article-title":"Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial","volume":"391","author":"Shepstone","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.aprim.2022.102471_bib2225","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1157\/13110466","article-title":"Fractura Osteopor\u00f3tica: Valoraci\u00f3n del riesgo en la pr\u00e1ctica cl\u00ednica","volume":"129","author":"V\u00e1zquez D\u00edaz","year":"2007","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.aprim.2022.102471_bib2230","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00198-004-1689-z","article-title":"The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach","volume":"16","author":"De Laet","year":"2005","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.aprim.2022.102471_bib2235","unstructured":"Direcci\u00f3n General de Farmacia y Productos Sanitarios. Recomendaciones para la valoraci\u00f3n y tratamiento de la osteoporosis primaria en mujeres de la Comunidad de Madrid. Madrid: Comunidad de Madrid. Consejer\u00eda de Sanidad; 2007."},{"key":"10.1016\/j.aprim.2022.102471_bib2240","unstructured":"Osteoporosis: Diagnosis, treatment and fracture risk. Guidelines and Protocols Advisory Committee, approved by the British Columbia Medical Association and adopted by the Medical Services Commission. 2011."},{"key":"10.1016\/j.aprim.2022.102471_bib2310","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.medcli.2012.11.031","article-title":"Prediction of frailty fractures or prediction of densitometric osteoporosis","volume":"141","author":"Azagra","year":"2013","journal-title":"That is the question! Med Clin (Barc)."},{"year":"2015","series-title":"Servicio Madrile\u00f1o de Salud. Recomendaciones para la valoraci\u00f3n y tratamiento de la osteoporosis primaria en mujeres de la Comunidad de Madrid","author":"Revilla Abad","key":"10.1016\/j.aprim.2022.102471_bib2250"},{"key":"10.1016\/j.aprim.2022.102471_bib2255","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/jbmr.248","article-title":"Absolute fracture risk assessment using lumbar spine and femoral neck bone density measurements: derivation and validation of a hybrid system","volume":"26","author":"Leslie","year":"2011","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.aprim.2022.102471_bib2260","first-page":"973","article-title":"Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society","year":"2021","journal-title":"Menopause."},{"key":"10.1016\/j.aprim.2022.102471_bib2265","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2022.102471_bib2270","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2022.102471_bib2275","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jamainternmed.2021.6745","article-title":"Time to Benefit of Bisphosphonate Therapy for the Prevention of Fractures Among PostmenopausalWomen With Osteoporosis A Meta-analysis of Randomized Clinical Trials","volume":"182","author":"Deardorff","year":"2022","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.aprim.2022.102471_bib2280","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00198-008-0813-x","article-title":"To stop or not stop, that is the question","volume":"20","author":"Seeman","year":"2009","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.aprim.2022.102471_bib2285","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11657-021-01000-w","article-title":"Discontinuation of bisphosphonates in seniors: a systematic review on health outcomes","volume":"16","author":"Lamarre","year":"2021","journal-title":"Archives Osteoporos"},{"key":"10.1016\/j.aprim.2022.102471_bib2290","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM Trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.aprim.2022.102471_bib2315","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/joim.13354","article-title":"Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: a population-based cohort study","volume":"290","author":"Fu","year":"2021","journal-title":"J Intern Med."},{"key":"10.1016\/j.aprim.2022.102471_bib2320","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/bmj.39435.656250.AD","article-title":"Drugs for pre-osteoporosis: prevention or disease mongering?","volume":"336","author":"Alonso Coello","year":"2008","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2022.102471_bib2325","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1808082","article-title":"Fracture Prevention with Zoledronate in Older Women with Osteopenia","volume":"379","author":"Reid","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2022.102471_bib2330","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7326\/0003-4819-144-11-200606060-00009","article-title":"Meta-Analysis: Accuracy of Quantitative ultrasound for identifying Patients with Osteoporosis","volume":"144","author":"Nayak","year":"2006","journal-title":"Ann Intern Med."}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656722001913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656722001913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:05:27Z","timestamp":1759323927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656722001913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":263,"alternative-id":["S0212656722001913"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2022.102471","relation":{},"ISSN":["0212-6567"],"issn-type":[{"type":"print","value":"0212-6567"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actividades preventivas en la mujer. Actualizaci\u00f3n PAPPS 2022","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2022.102471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102471"}}